USA flag logo/image

An Official Website of the United States Government

A2A Adenosine Receptors and Equine Sepsis

Award Information

Agency:
Department of Agriculture
Branch:
N/A
Award ID:
61989
Program Year/Program:
2006 / SBIR
Agency Tracking Number:
2003-00471
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ADENOSINE THERAPEUTICS, LLC
310 FOURTH STREET NE SUITE 201 CHARLOTTESVILLE, VA 22902
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2006
Title: A2A Adenosine Receptors and Equine Sepsis
Agency: USDA
Contract: 2006-33610-17725
Award Amount: $296,000.00
 

Abstract:

Endotoxemia (Sepsis) affects horses of all breeds and ages and is the leading causes of death in adult horses and foals. Consequently, its economic impact on the equine industry in the United States is devastating. This project seeks to develop new treatments for this disease.

Principal Investigator:

Robert Thompson
4349519484
rdt@adenrx.com

Business Contact:

Robert S. Capon
CEO
4342209400
rob@adenrx.com
Small Business Information at Submission:

Adenosine Therapeutics, LLC
1670 Discovery Dr., Ste. 212 Charlottesville, VA 22911

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No